Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** A preparation of allogeneic CD8+ T cells targeting multiple undisclosed leukemia-associated antigens, with potential immunomodulating and antineoplastic activities. Following peripheral blood mononuclear cell (PBMC) collection from the original stem cell donor and ex vivo priming and expansion, the allogeneic CD8+ leukemia-associated antigens specific T cells NEXI-001 are re-introduced into the leukemia patient, where they target and kill tumor cells expressing these leukemia-associated antigens.

**Synonyms:** - NEXI 001 - NEXI-001 - NEXI001